Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review
{{output}}
Background: Diabetic nephropathy (DN) is the main cause of chronic kidney disease and end-stage renal disease worldwide. Although available clinical trials have shown that endothelin receptor (ER) antagonists may be a novel and b... ...
